An RSV vaccine has been available to pregnant women in Northern Ireland since last September and is offered from 28 weeks of ...

Vaccination of pregnant women has been linked to a drop in newborns being admitted to hospital with a serious lung infection, ...

Researchers looked at the cases of 537 babies in England and Scotland who were admitted to hospital with severe respiratory ...

The new injection, Nirsevimab, will be given to high-risk babies, including those born too early to be protected by the RSV ...

RSV can lead to a severe lung infection called bronchiolitis, which is dangerous in babies and can result in them being admitted to intensive care. It is the main infectious cause of hospitalisation ...

A new injection will be offered to babies born very prematurely in Wales to protect them against a common winter virus. The ...

The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

New research from the Children’s Hospital of Philadelphia shows the challenges of getting families to accept a promising new drug that protects against RSV, a common cold-like virus that can cause ...

Since the start of February, pregnant women have been eligible to get vaccinated against respiratory syncytial virus (RSV).  The vaccine is administered during the 28 to 36 week mark of pregnancy to ...

The online tool CoVerage can detect and characterize SARS-CoV-2 Variants of Concern (VOCs) up to three months before their formal designation of the WHO.